Allspring Global Investments Holdings, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 26 shares of RYTM stock, worth $1,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26
Previous 379
93.14%
Holding current value
$1,612
Previous $15,000
93.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RYTM
# of Institutions
192Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$448 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$418 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$397 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$377 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$241 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.46B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...